ArticleBMC nephrology2026
Comparison of efficacy and safety among four therapeutic regimens in primary membranous nephropathy with high anti-PLA2R antibody titers: a single-center retrospective cohort study.
Yuxiu Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.